NM

R New Jersey General Assembly · District 21

Asm. Nancy Muñoz

Contact Email Phone Official site ↗

Compare

Total votes

5,751

all sessions

Attendance

94%

278 missed

Near the chamber average

With party

96%

of cast votes

Lower than 82% of chamber peers

Bipartisan score

3%

crosses aisle rarely

Higher than 82% of chamber peers

Voting record

Yea

4,550

voted in favor

Nay

743

voted against

Absent

278

missed votes

Total cast

5,751

across all sessions

Crossed party

197

votes against own party

This page

5,751

matching current filters

Bill

Description

Vote

Result

Tally

Date

A 4975

Establishes crime of possessing digital instructions to illegally manufacture firearms and firearm components. Against party

Yea

Passed

50–26

Mar 24, 2025

A 1148

Provides for background checks and other requirements for certain agencies providing temporary home for child or pregnant woman during crisis.

Yea

Passed

10–0

Mar 20, 2025

A 5278

Establishes "New Jersey Menopause Coverage Act"; requires health insurance coverage of medically necessary perimenopause and menopause treatments.

Yea

Passed

9–0

Mar 20, 2025

A 5459

Extends time period in which to enroll newborn infant in health benefits coverage.

Yea

Passed

10–0

Mar 20, 2025

A 1799

Requires DOH to develop shared decision-making tool and establish maternal health care pilot program. Bipartisan

Yea

Passed

8–2

Mar 20, 2025

A 5309

Permits up to three credits of continuing medical education on menopause to be used by nurses and physicians for license renewal.*

Yea

Passed

10–0

Mar 20, 2025

A 3546

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

Yea

Passed

10–0

Mar 20, 2025

A 4589

Permits use of credit card, debit card, or other electronic payment for raffles and penny auctions.*

Yea

Passed

4–0

Mar 6, 2025

SJR 140

Designates month of March of each year as "Amyloidosis Awareness Month."

Yea

Passed

11–0

Mar 6, 2025

A 4767

Limits regulated perfluoroalkyl and polyfluoroalkyl substances in menstrual products.*

Yea

Passed

4–0

Mar 6, 2025